Blockade of the ERK pathway enhances the therapeutic efficacy of the histone deacetylase inhibitor MS-275 in human tumor xenograft models. (Q51824498)
Jump to navigation
Jump to search
scientific article published on 15 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Blockade of the ERK pathway enhances the therapeutic efficacy of the histone deacetylase inhibitor MS-275 in human tumor xenograft models. |
scientific article published on 15 March 2013 |
Statements
1 reference
Blockade of the ERK pathway enhances the therapeutic efficacy of the histone deacetylase inhibitor MS-275 in human tumor xenograft models. (English)
1 reference
Toshiaki Sakamoto
1 reference
Kei-ichi Ozaki
1 reference
Kohsuke Fujio
1 reference
Shu-hei Kajikawa
1 reference
Shin-ichi Uesato
1 reference
Kazushi Watanabe
1 reference
Susumu Tanimura
1 reference
Takehiko Koji
1 reference
Michiaki Kohno
1 reference
15 March 2013
1 reference
433
1 reference
4
1 reference
456-462
1 reference
Identifiers
1 reference